基本情報
- 標準SMILES
CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl- InChIKey
XWIHRGFIPXWGEF-UHFFFAOYSA-N- 分子式
- C21H28ClNO3
- 平均分子量
- 377.9 g/mol
- 単同位体質量
- 377.17577144
概要
Propafenone hydrochloride is a hydrochloride that is the monohydrochloride salt of propafenone. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used in the management of supraventricular and ventricular arrhythmias. It has a role as an anti-arrhythmia drug. It contains a propafenone(1+).
名称と識別子
- 優先名称
- Propafenone Hydrochloride
- IUPAC
- 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride
名称と別名
名称をさらに表示
データベース識別子
- CAS
34183-22-7- PubChem CID
- 36708
- DTXSID
DTXSID101017233- ChEMBL
CHEMBL1201063- ChEBI
CHEBI:8466- UNII
- 33XCH0HOCD
- EC Number
- 251-867-9
物性
構造計算による物性
- 極性表面積
- 58.6 Ų
- 水素結合供与体数
- 3
- 水素結合受容体数
- 4
- 回転可能結合数
- 11
- 重原子数
- 26
- 形式電荷
- 0
- 複雑度
- 368
実験および物理化学的性質
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全と法規制
GHS分類
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 154 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
毒性情報
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Propafenone hydrochloride
vLess-DILI-concern
3
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
化学と産業
薬理情報
FDA Pharmacological Classification
PROPAFENONE HYDROCHLORIDE
Antiarrhythmic [EPC]
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.
関連反応
関連ノート
読み込み中…